Screener
Amgen AMGN Business Segments — G&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Profit share and royalties in cost of sales(1) | 672 | 527 | 1,236 | 967 |
| Research and development(1) | 1,868 | 1,744 | 3,587 | 3,230 |
| Sales and marketing(1) | 1,155 | 1,137 | 2,289 | 2,203 |
| General and administrative(1) | 590 | 554 | 1,058 | 1,175 |
| Other segment items(3) | 314 | 557 | 227 | (5) |
| Interest income | (125) | (86) | (226) | (212) |
| Interest expense, net | 673 | 694 | 1,330 | 1,417 |
| Provision for income taxes | 393 | 136 | 658 | 379 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's business segments — G&A?
- Amgen (AMGN) reported business segments — G&A of $590M in Q2 2026.
- How has Amgen's business segments — G&A changed year-over-year?
- Amgen's business segments — G&A increased by 6.5% year-over-year, from $554M to $590M.
- What does business segments — G&A mean?
- Covers the overhead costs of operating the business, including executive compensation, legal, finance, and corporate infrastructure. These expenses are necessary for the day-to-day management and compliance of the organization. Efficient management of these costs is key to maximizing operating margins.
Ask your AI about Amgen's business segments — g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude